Cytomegalovirus Reactivation During Maintenance Therapy in Non-transplant Pediatric Acute Lymphoblastic Leukemia
- 5 March 2026
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- p. 1-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Expert consensus on the management of cytomegalovirus infection in pediatric allogeneic hematopoietic stem cell transplantationCurrent Research in Translational Medicine, 2025
- Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from IndiaThe Lancet Regional Health - Southeast Asia, 2025
- Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapiesThe Lancet Infectious Diseases, 2025
- Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections ForumClinical Infectious Diseases, 2024
- Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysisThe Lancet Oncology, 2023
- Cytomegalovirus viremia among pediatric oncology non-stem cell transplant patients with prolonged fever neutropeniaJournal of Infection and Public Health, 2020
- Cytomegalovirus disease in a retinoblastoma cohort: The role of preemptive screeningPediatric Blood & Cancer, 2019
- Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta‐analysisReviews in Medical Virology, 2019
- Viral Infections2018
- Cytomegalovirus induced hemophagocytic lymphocytic histiocytosis in two pediatric patients with acute lymphoblastic leukemiaIDCases, 2017